Chemo-immunotherapy for unresectable bronchogenic carcinoma.

  title={Chemo-immunotherapy for unresectable bronchogenic carcinoma.},
  author={Gregory P. Sarna and Barry B. Lowitz and Charles M. Haskell and Frederick J. Dorey and Martin J. Cline},
  journal={Cancer treatment reports},
  volume={62 5},
Seventy-nine patients with metastatic or unresectable bronchogenic carcinoma were treated with a regimen of combination chemotherapy which included methotrexate, Oncovin (vincristine), cyclophosphamide, and adriamycin (MOCA), and were randomized to receive no additional therapy, immunotherapy with bacillus Calmette-Guérin, or immunotherapy with Corynebacterium parvum (C. parvum). The response rate and estimated median survival time were 68% and 42 weeks in small cell carcinoma and 18% and 29… CONTINUE READING
2 Citations
0 References
Similar Papers


Publications citing this paper.

Similar Papers

Loading similar papers…